Allowed Publications
MDedge Family Medicine
The Journal of Family Practice
Slot System
Featured Buckets
Featured Buckets Admin
Reverse Chronological Sort

ACIP simplifies adult vaccinations for HepB and pneumonia

Article Type
Audio
Changed
Wed, 12/08/2021 - 19:11
Display Headline
ACIP simplifies adult vaccinations for HepB and pneumonia
Author(s)
Doug Campos-Outcalt, MD, MPA

REFERENCES

  1. Weng MK. Universal adult hepatitis B vaccinations: work group considerations. Presented to the Advisory Committee on Immunization Practices on November 3, 2021. Accessed November 17, 2021. www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-11-2-3/02-HepWG-weng-508.pdf
  2. Kovayashi M. Considerations for age-based and risk-based use of PCV15 and PCV20 among US adults and proposed policy options. Presented to the Advisory Committee on Immunization Practices on October 20, 2021. Accessed November 17, 2021. www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-10-20-21/02-Pneumococcal-Kobayashi-508.pdf
  3. Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018;67:1-31.
  4. Matanock A, Lee G, Gierke R, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morbid Mortal Wkly Rep. 2019;68:1069-1075.
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Issue
The Journal of Family Practice - 70(10)
Publications
MDedge Family Medicine
The Journal of Family Practice
Topics
Vaccines
Infectious Diseases
Page Number
audio
Sections
Practice Alert Podcast
Author(s)
Doug Campos-Outcalt, MD, MPA
Author(s)
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

REFERENCES

  1. Weng MK. Universal adult hepatitis B vaccinations: work group considerations. Presented to the Advisory Committee on Immunization Practices on November 3, 2021. Accessed November 17, 2021. www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-11-2-3/02-HepWG-weng-508.pdf
  2. Kovayashi M. Considerations for age-based and risk-based use of PCV15 and PCV20 among US adults and proposed policy options. Presented to the Advisory Committee on Immunization Practices on October 20, 2021. Accessed November 17, 2021. www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-10-20-21/02-Pneumococcal-Kobayashi-508.pdf
  3. Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018;67:1-31.
  4. Matanock A, Lee G, Gierke R, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morbid Mortal Wkly Rep. 2019;68:1069-1075.

REFERENCES

  1. Weng MK. Universal adult hepatitis B vaccinations: work group considerations. Presented to the Advisory Committee on Immunization Practices on November 3, 2021. Accessed November 17, 2021. www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-11-2-3/02-HepWG-weng-508.pdf
  2. Kovayashi M. Considerations for age-based and risk-based use of PCV15 and PCV20 among US adults and proposed policy options. Presented to the Advisory Committee on Immunization Practices on October 20, 2021. Accessed November 17, 2021. www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-10-20-21/02-Pneumococcal-Kobayashi-508.pdf
  3. Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018;67:1-31.
  4. Matanock A, Lee G, Gierke R, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morbid Mortal Wkly Rep. 2019;68:1069-1075.
Issue
The Journal of Family Practice - 70(10)
Issue
The Journal of Family Practice - 70(10)
Page Number
audio
Page Number
audio
Publications
MDedge Family Medicine
The Journal of Family Practice
Publications
MDedge Family Medicine
The Journal of Family Practice
Topics
Vaccines
Infectious Diseases
Article Type
Audio
Display Headline
ACIP simplifies adult vaccinations for HepB and pneumonia
Display Headline
ACIP simplifies adult vaccinations for HepB and pneumonia
Sections
Practice Alert Podcast
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 11/16/2021 - 13:15
Un-Gate On Date
Tue, 11/16/2021 - 13:15
Use ProPublica
CFC Schedule Remove Status
Tue, 11/16/2021 - 13:15
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Teaser Media
Doug Campos-Outcalt, MD, MPA

Beyond the headlines: A closer look at the USPSTF draft recs on aspirin

Article Type
Audio
Changed
Wed, 11/10/2021 - 09:38
Display Headline
Beyond the headlines: A closer look at the USPSTF draft recs on aspirin
Author(s)
Doug Campos-Outcalt, MD, MPA

REFERENCES

  1. US Preventive Services Task Force. Aspirin use to prevent cardiovascular disease: preventive medication. Published October 12, 2021. Accessed October 25, 2021. www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
  2. National Center for Health Statistics. Figure 4. Number of deaths, percentage of total deaths, and age-adjusted death rates for the 10 leading causes of death in 2019: United States, 2018 and 2019. In: Data Brief 395: Mortality in the United States 2019. Published December 2020. Accessed October 25, 2021. www.cdc.gov/nchs/data/databriefs/db395-tables-508.pdf
  3. American College of Cardiology/American Heart Association. Heart risk calculator. Updated November 12, 2017. Accessed October 25, 2021. www.cvriskcalculator.com/
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Issue
The Journal of Family Practice - 70(9)
Publications
MDedge Family Medicine
The Journal of Family Practice
Topics
Cardiology
Page Number
audio
Sections
Practice Alert Podcast
Author(s)
Doug Campos-Outcalt, MD, MPA
Author(s)
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

REFERENCES

  1. US Preventive Services Task Force. Aspirin use to prevent cardiovascular disease: preventive medication. Published October 12, 2021. Accessed October 25, 2021. www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
  2. National Center for Health Statistics. Figure 4. Number of deaths, percentage of total deaths, and age-adjusted death rates for the 10 leading causes of death in 2019: United States, 2018 and 2019. In: Data Brief 395: Mortality in the United States 2019. Published December 2020. Accessed October 25, 2021. www.cdc.gov/nchs/data/databriefs/db395-tables-508.pdf
  3. American College of Cardiology/American Heart Association. Heart risk calculator. Updated November 12, 2017. Accessed October 25, 2021. www.cvriskcalculator.com/

REFERENCES

  1. US Preventive Services Task Force. Aspirin use to prevent cardiovascular disease: preventive medication. Published October 12, 2021. Accessed October 25, 2021. www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
  2. National Center for Health Statistics. Figure 4. Number of deaths, percentage of total deaths, and age-adjusted death rates for the 10 leading causes of death in 2019: United States, 2018 and 2019. In: Data Brief 395: Mortality in the United States 2019. Published December 2020. Accessed October 25, 2021. www.cdc.gov/nchs/data/databriefs/db395-tables-508.pdf
  3. American College of Cardiology/American Heart Association. Heart risk calculator. Updated November 12, 2017. Accessed October 25, 2021. www.cvriskcalculator.com/
Issue
The Journal of Family Practice - 70(9)
Issue
The Journal of Family Practice - 70(9)
Page Number
audio
Page Number
audio
Publications
MDedge Family Medicine
The Journal of Family Practice
Publications
MDedge Family Medicine
The Journal of Family Practice
Topics
Cardiology
Article Type
Audio
Display Headline
Beyond the headlines: A closer look at the USPSTF draft recs on aspirin
Display Headline
Beyond the headlines: A closer look at the USPSTF draft recs on aspirin
Sections
Practice Alert Podcast
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 10/26/2021 - 07:45
Un-Gate On Date
Tue, 10/26/2021 - 07:45
Use ProPublica
CFC Schedule Remove Status
Tue, 10/26/2021 - 07:45
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Teaser Media
Doug Campos-Outcalt, MD, MPA

USPSTF updates diabetes recs, lowers screening age

Article Type
Audio
Changed
Tue, 05/03/2022 - 15:04
Display Headline
USPSTF updates diabetes recs, lowers screening age
Author(s)
Doug Campos-Outcalt, MD, MPA

REFERENCES

  1. US Preventive Services Task Force. Screening for prediabetes and type 2 diabetes. JAMA. 2021;326:736-743. doi: 10.1001/jama.2021.12531
  2. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2021;44(suppl 1):S15-S33. https://doi.org/10.2337/dc21-S002
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Issue
The Journal of Family Practice - 70(8)
Publications
MDedge Family Medicine
The Journal of Family Practice
Type 2 Diabetes ICYMI
Topics
Diabetes
Preventive Care
Page Number
audio
Sections
Practice Alert Podcast
Author(s)
Doug Campos-Outcalt, MD, MPA
Author(s)
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

REFERENCES

  1. US Preventive Services Task Force. Screening for prediabetes and type 2 diabetes. JAMA. 2021;326:736-743. doi: 10.1001/jama.2021.12531
  2. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2021;44(suppl 1):S15-S33. https://doi.org/10.2337/dc21-S002

REFERENCES

  1. US Preventive Services Task Force. Screening for prediabetes and type 2 diabetes. JAMA. 2021;326:736-743. doi: 10.1001/jama.2021.12531
  2. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2021;44(suppl 1):S15-S33. https://doi.org/10.2337/dc21-S002
Issue
The Journal of Family Practice - 70(8)
Issue
The Journal of Family Practice - 70(8)
Page Number
audio
Page Number
audio
Publications
MDedge Family Medicine
The Journal of Family Practice
Type 2 Diabetes ICYMI
Publications
MDedge Family Medicine
The Journal of Family Practice
Type 2 Diabetes ICYMI
Topics
Diabetes
Preventive Care
Article Type
Audio
Display Headline
USPSTF updates diabetes recs, lowers screening age
Display Headline
USPSTF updates diabetes recs, lowers screening age
Sections
Practice Alert Podcast
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Thu, 09/30/2021 - 12:15
Un-Gate On Date
Thu, 09/30/2021 - 12:15
Use ProPublica
CFC Schedule Remove Status
Thu, 09/30/2021 - 12:15
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Teaser Media
Doug Campos-Outcalt, MD, MPA

Hypertension in adults: USPSTF reaffirms this screening protocol

Article Type
Audio
Changed
Wed, 09/15/2021 - 10:28
Display Headline
Hypertension in adults: USPSTF reaffirms this screening protocol
Author(s)
Doug Campos-Outcalt, MD, MPA

REFERENCES

  1. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026
  2. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127-e248.
  3. US Preventive Services Task Force. Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2021;325:1650-1656. doi: 10.1001/jama.2021.4987
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Issue
The Journal of Family Practice - 70(7)
Publications
MDedge Family Medicine
The Journal of Family Practice
Topics
Cardiology
Page Number
audio
Sections
Practice Alert Podcast
Author(s)
Doug Campos-Outcalt, MD, MPA
Author(s)
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

REFERENCES

  1. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026
  2. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127-e248.
  3. US Preventive Services Task Force. Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2021;325:1650-1656. doi: 10.1001/jama.2021.4987

REFERENCES

  1. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026
  2. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127-e248.
  3. US Preventive Services Task Force. Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2021;325:1650-1656. doi: 10.1001/jama.2021.4987
Issue
The Journal of Family Practice - 70(7)
Issue
The Journal of Family Practice - 70(7)
Page Number
audio
Page Number
audio
Publications
MDedge Family Medicine
The Journal of Family Practice
Publications
MDedge Family Medicine
The Journal of Family Practice
Topics
Cardiology
Article Type
Audio
Display Headline
Hypertension in adults: USPSTF reaffirms this screening protocol
Display Headline
Hypertension in adults: USPSTF reaffirms this screening protocol
Sections
Practice Alert Podcast
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 08/17/2021 - 07:45
Un-Gate On Date
Tue, 08/17/2021 - 07:45
Use ProPublica
CFC Schedule Remove Status
Tue, 08/17/2021 - 07:45
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Teaser Media
Doug Campos-Outcalt, MD, MPA

Healthy weight gain in pregnancy: What the USPSTF recommends

Article Type
Audio
Changed
Tue, 08/17/2021 - 07:44
Display Headline
Healthy weight gain in pregnancy: What the USPSTF recommends
Author(s)
Doug Campos-Outcalt, MD, MPA

REFERENCES

  1. US Preventive Services Task Force. Behavioral counseling interventions for healthy weight and weight gain in pregnancy: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:2087-2092. doi:10.1001/jama.2021.6949
  2. Rasmussen KM, Yaktine AL, eds. Weight Gain During Pregnancy: Reexamining the Guidelines. National Academies Press; 2009. doi: 10.17226/12584
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Issue
The Journal of Family Practice - 70(6)
Publications
MDedge Family Medicine
The Journal of Family Practice
Topics
Women's Health
Obesity
Page Number
audio
Sections
Practice Alert Podcast
Author(s)
Doug Campos-Outcalt, MD, MPA
Author(s)
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

REFERENCES

  1. US Preventive Services Task Force. Behavioral counseling interventions for healthy weight and weight gain in pregnancy: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:2087-2092. doi:10.1001/jama.2021.6949
  2. Rasmussen KM, Yaktine AL, eds. Weight Gain During Pregnancy: Reexamining the Guidelines. National Academies Press; 2009. doi: 10.17226/12584

REFERENCES

  1. US Preventive Services Task Force. Behavioral counseling interventions for healthy weight and weight gain in pregnancy: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:2087-2092. doi:10.1001/jama.2021.6949
  2. Rasmussen KM, Yaktine AL, eds. Weight Gain During Pregnancy: Reexamining the Guidelines. National Academies Press; 2009. doi: 10.17226/12584
Issue
The Journal of Family Practice - 70(6)
Issue
The Journal of Family Practice - 70(6)
Page Number
audio
Page Number
audio
Publications
MDedge Family Medicine
The Journal of Family Practice
Publications
MDedge Family Medicine
The Journal of Family Practice
Topics
Women's Health
Obesity
Article Type
Audio
Display Headline
Healthy weight gain in pregnancy: What the USPSTF recommends
Display Headline
Healthy weight gain in pregnancy: What the USPSTF recommends
Sections
Practice Alert Podcast
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Fri, 07/09/2021 - 13:00
Un-Gate On Date
Fri, 07/09/2021 - 13:00
Use ProPublica
CFC Schedule Remove Status
Fri, 07/09/2021 - 13:00
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Teaser Media
Doug Campos-Outcalt, MD, MPA

COVID-19 vaccine update: Uptake, effectiveness, and safety concerns

Article Type
Audio
Changed
Thu, 08/26/2021 - 15:46
Display Headline
COVID-19 vaccine update: Uptake, effectiveness, and safety concerns
Author(s)
Doug Campos-Outcalt, MD, MPA

 

REFERENCES

  1. CDC. COVID Data Tracker. Accessed June 3, 2021. https://covid.cdc.gov/covid-data-tracker/#datatracker-home
  2. WHO Coronavirus (COVID-19) Dashboard. Accessed June 3, 2021. https://covid19.who.int/
  3. CDC. Demographic trends of people receiving COVID-19 vaccinations in the United States. Accessed June 3, 2021. https://covid.cdc.gov/covid-data-tracker/#vaccination-demographics-trends
  4. Shimabukuro T. Update: thrombosis with thrombocytopenia syndrome (TTS) following COVID-19 vaccination. Presentation to the Advisory Committee on Immunization Practices, May 12, 2021. Accessed June 3, 2021. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-05-12/07-COVID-Shimabukuro-508.pdf
  5. Fleming-Dutra K. CDC COVID-19 vaccine effectiveness studies. Presentation to the Advisory Committee on Immunization Practices, May 12, 2021. Accessed June 3, 2021. www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-05-12/09-COVID-Fleming-Dutra-508.pdf
  6. Scobie H. Update on emerging SARS-CoV-2 variants and vaccine considerations. Presentation to the Advisory Committee on Immunization Practices, May 12, 2021. Accessed June 3, 2021. www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-05-12/10-COVID-Scobie-508.pdf
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Issue
The Journal of Family Practice - 70(5)
Publications
MDedge Family Medicine
The Journal of Family Practice
Covid ICYMI
Topics
COVID-19 Updates
Vaccines
Infectious Diseases
Page Number
audio
Sections
Practice Alert Podcast
Author(s)
Doug Campos-Outcalt, MD, MPA
Author(s)
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

 

REFERENCES

  1. CDC. COVID Data Tracker. Accessed June 3, 2021. https://covid.cdc.gov/covid-data-tracker/#datatracker-home
  2. WHO Coronavirus (COVID-19) Dashboard. Accessed June 3, 2021. https://covid19.who.int/
  3. CDC. Demographic trends of people receiving COVID-19 vaccinations in the United States. Accessed June 3, 2021. https://covid.cdc.gov/covid-data-tracker/#vaccination-demographics-trends
  4. Shimabukuro T. Update: thrombosis with thrombocytopenia syndrome (TTS) following COVID-19 vaccination. Presentation to the Advisory Committee on Immunization Practices, May 12, 2021. Accessed June 3, 2021. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-05-12/07-COVID-Shimabukuro-508.pdf
  5. Fleming-Dutra K. CDC COVID-19 vaccine effectiveness studies. Presentation to the Advisory Committee on Immunization Practices, May 12, 2021. Accessed June 3, 2021. www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-05-12/09-COVID-Fleming-Dutra-508.pdf
  6. Scobie H. Update on emerging SARS-CoV-2 variants and vaccine considerations. Presentation to the Advisory Committee on Immunization Practices, May 12, 2021. Accessed June 3, 2021. www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-05-12/10-COVID-Scobie-508.pdf

 

REFERENCES

  1. CDC. COVID Data Tracker. Accessed June 3, 2021. https://covid.cdc.gov/covid-data-tracker/#datatracker-home
  2. WHO Coronavirus (COVID-19) Dashboard. Accessed June 3, 2021. https://covid19.who.int/
  3. CDC. Demographic trends of people receiving COVID-19 vaccinations in the United States. Accessed June 3, 2021. https://covid.cdc.gov/covid-data-tracker/#vaccination-demographics-trends
  4. Shimabukuro T. Update: thrombosis with thrombocytopenia syndrome (TTS) following COVID-19 vaccination. Presentation to the Advisory Committee on Immunization Practices, May 12, 2021. Accessed June 3, 2021. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-05-12/07-COVID-Shimabukuro-508.pdf
  5. Fleming-Dutra K. CDC COVID-19 vaccine effectiveness studies. Presentation to the Advisory Committee on Immunization Practices, May 12, 2021. Accessed June 3, 2021. www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-05-12/09-COVID-Fleming-Dutra-508.pdf
  6. Scobie H. Update on emerging SARS-CoV-2 variants and vaccine considerations. Presentation to the Advisory Committee on Immunization Practices, May 12, 2021. Accessed June 3, 2021. www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-05-12/10-COVID-Scobie-508.pdf
Issue
The Journal of Family Practice - 70(5)
Issue
The Journal of Family Practice - 70(5)
Page Number
audio
Page Number
audio
Publications
MDedge Family Medicine
The Journal of Family Practice
Covid ICYMI
Publications
MDedge Family Medicine
The Journal of Family Practice
Covid ICYMI
Topics
COVID-19 Updates
Vaccines
Infectious Diseases
Article Type
Audio
Display Headline
COVID-19 vaccine update: Uptake, effectiveness, and safety concerns
Display Headline
COVID-19 vaccine update: Uptake, effectiveness, and safety concerns
Sections
Practice Alert Podcast
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Thu, 06/03/2021 - 13:30
Un-Gate On Date
Thu, 06/03/2021 - 13:30
Use ProPublica
CFC Schedule Remove Status
Thu, 06/03/2021 - 13:30
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Teaser Media
Doug Campos-Outcalt, MD, MPA

USPSTF makes 2 major changes to its lung cancer screening recs

Article Type
Audio
Changed
Thu, 05/13/2021 - 15:14
Display Headline
USPSTF makes 2 major changes to its lung cancer screening recs
Author(s)
Doug Campos-Outcalt, MD, MPA

REFERENCES

  1. American Academy of Family Physicians. Lung cancer: lung cancer screening in adults. AAFP Clinical Preventive Service Recommendations. Accessed April 26, 2021. www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/lung-cancer.html
  2. USPSTF. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:962-970. doi:10.1001/jama.2021.1117
  3. Jonas DE, Reuland DS, Reddy, SM, et al. Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325:971-987. doi:10.1001/jama.2021.0377
  4. Henderson LM, Rivera MP, Basch E. Broadened eligibility for lung cancer screening: challenges and uncertainty for implementation and equity. JAMA. 2021;325:939-941. doi:10.1001/jama.2020.26422
  5. Meza R, Jeon J, Toumazis I, et al. Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force. JAMA. 2021;325:988-997. doi:10.1001/jama.2021.1077
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Issue
The Journal of Family Practice - 70(4)
Publications
MDedge Family Medicine
The Journal of Family Practice
Topics
Oncology
Page Number
audio
Sections
Practice Alert Podcast
Author(s)
Doug Campos-Outcalt, MD, MPA
Author(s)
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

REFERENCES

  1. American Academy of Family Physicians. Lung cancer: lung cancer screening in adults. AAFP Clinical Preventive Service Recommendations. Accessed April 26, 2021. www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/lung-cancer.html
  2. USPSTF. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:962-970. doi:10.1001/jama.2021.1117
  3. Jonas DE, Reuland DS, Reddy, SM, et al. Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325:971-987. doi:10.1001/jama.2021.0377
  4. Henderson LM, Rivera MP, Basch E. Broadened eligibility for lung cancer screening: challenges and uncertainty for implementation and equity. JAMA. 2021;325:939-941. doi:10.1001/jama.2020.26422
  5. Meza R, Jeon J, Toumazis I, et al. Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force. JAMA. 2021;325:988-997. doi:10.1001/jama.2021.1077

REFERENCES

  1. American Academy of Family Physicians. Lung cancer: lung cancer screening in adults. AAFP Clinical Preventive Service Recommendations. Accessed April 26, 2021. www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/lung-cancer.html
  2. USPSTF. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:962-970. doi:10.1001/jama.2021.1117
  3. Jonas DE, Reuland DS, Reddy, SM, et al. Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325:971-987. doi:10.1001/jama.2021.0377
  4. Henderson LM, Rivera MP, Basch E. Broadened eligibility for lung cancer screening: challenges and uncertainty for implementation and equity. JAMA. 2021;325:939-941. doi:10.1001/jama.2020.26422
  5. Meza R, Jeon J, Toumazis I, et al. Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force. JAMA. 2021;325:988-997. doi:10.1001/jama.2021.1077
Issue
The Journal of Family Practice - 70(4)
Issue
The Journal of Family Practice - 70(4)
Page Number
audio
Page Number
audio
Publications
MDedge Family Medicine
The Journal of Family Practice
Publications
MDedge Family Medicine
The Journal of Family Practice
Topics
Oncology
Article Type
Audio
Display Headline
USPSTF makes 2 major changes to its lung cancer screening recs
Display Headline
USPSTF makes 2 major changes to its lung cancer screening recs
Sections
Practice Alert Podcast
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Mon, 04/26/2021 - 13:15
Un-Gate On Date
Mon, 04/26/2021 - 13:15
Use ProPublica
CFC Schedule Remove Status
Mon, 04/26/2021 - 13:15
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Teaser Media
Doug Campos-Outcalt, MD, MPA

CDC’s new gonorrhea treatment recs: What’s changed, and when to retest

Article Type
Audio
Changed
Mon, 04/26/2021 - 13:24
Display Headline
CDC’s new gonorrhea treatment recs: What’s changed, and when to retest
Author(s)
Doug Campos-Outcalt, MD, MPA

REFERENCES

  1. CDC. Expedited partner therapy. Accessed March 15, 2021. www.cdc.gov/std/ept/default.htm
  2. St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC's treatment guidelines for gonococcal infection, 2020. MMWR Morbid Mortal Wkly Rep. 2020;69:1911-1916. Accessed March 15, 2021. https://www.cdc.gov/mmwr/volumes/69/wr/mm6950a6.htm
  3. CDC. Gonococcal infections. Accessed March 15, 2021. www.cdc.gov/std/tg2015/gonorrhea.htm
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Issue
The Journal of Family Practice - 70(3)
Publications
MDedge Family Medicine
The Journal of Family Practice
Topics
Infectious Diseases
Page Number
audio
Sections
Practice Alert Podcast
Author(s)
Doug Campos-Outcalt, MD, MPA
Author(s)
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

REFERENCES

  1. CDC. Expedited partner therapy. Accessed March 15, 2021. www.cdc.gov/std/ept/default.htm
  2. St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC's treatment guidelines for gonococcal infection, 2020. MMWR Morbid Mortal Wkly Rep. 2020;69:1911-1916. Accessed March 15, 2021. https://www.cdc.gov/mmwr/volumes/69/wr/mm6950a6.htm
  3. CDC. Gonococcal infections. Accessed March 15, 2021. www.cdc.gov/std/tg2015/gonorrhea.htm

REFERENCES

  1. CDC. Expedited partner therapy. Accessed March 15, 2021. www.cdc.gov/std/ept/default.htm
  2. St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC's treatment guidelines for gonococcal infection, 2020. MMWR Morbid Mortal Wkly Rep. 2020;69:1911-1916. Accessed March 15, 2021. https://www.cdc.gov/mmwr/volumes/69/wr/mm6950a6.htm
  3. CDC. Gonococcal infections. Accessed March 15, 2021. www.cdc.gov/std/tg2015/gonorrhea.htm
Issue
The Journal of Family Practice - 70(3)
Issue
The Journal of Family Practice - 70(3)
Page Number
audio
Page Number
audio
Publications
MDedge Family Medicine
The Journal of Family Practice
Publications
MDedge Family Medicine
The Journal of Family Practice
Topics
Infectious Diseases
Article Type
Audio
Display Headline
CDC’s new gonorrhea treatment recs: What’s changed, and when to retest
Display Headline
CDC’s new gonorrhea treatment recs: What’s changed, and when to retest
Sections
Practice Alert Podcast
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 03/16/2021 - 08:00
Un-Gate On Date
Tue, 03/16/2021 - 08:00
Use ProPublica
CFC Schedule Remove Status
Tue, 03/16/2021 - 08:00
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
Teaser Media
Doug Campos-Outcalt, MD, MPA

COVID-19 vaccines: New candidates & answers to commonly asked questions

Article Type
Audio
Changed
Thu, 08/26/2021 - 15:50
Display Headline
COVID-19 vaccines: New candidates & answers to commonly asked questions
Author(s)
Doug Campos-Outcalt, MD, MPA

REFERENCES

  1. CDC. COVID-19 vaccination. Accessed February 22, 2021.
  2. CDC. COVID data tracker. Accessed February 22, 2021.
  3. Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2020;69:1922-1924. Accessed February 22, 2021.
  4. Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2021;69:1653-1656. Accessed February 22, 2021.
  5. Gee J, Marquez P, Su J, et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. MMWR Morbid Mortal Wkly Rep. ePub: February 19, 2021. Accessed February 22, 2021.
  6. CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:125-129. Accessed February 25, 2021.
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Issue
The Journal of Family Practice - 70(2)
Publications
MDedge Family Medicine
The Journal of Family Practice
Covid ICYMI
Topics
COVID-19 Updates
Infectious Diseases
Vaccines
Page Number
audio
Sections
Practice Alert Podcast
Author(s)
Doug Campos-Outcalt, MD, MPA
Author(s)
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

REFERENCES

  1. CDC. COVID-19 vaccination. Accessed February 22, 2021.
  2. CDC. COVID data tracker. Accessed February 22, 2021.
  3. Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2020;69:1922-1924. Accessed February 22, 2021.
  4. Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2021;69:1653-1656. Accessed February 22, 2021.
  5. Gee J, Marquez P, Su J, et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. MMWR Morbid Mortal Wkly Rep. ePub: February 19, 2021. Accessed February 22, 2021.
  6. CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:125-129. Accessed February 25, 2021.

REFERENCES

  1. CDC. COVID-19 vaccination. Accessed February 22, 2021.
  2. CDC. COVID data tracker. Accessed February 22, 2021.
  3. Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2020;69:1922-1924. Accessed February 22, 2021.
  4. Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2021;69:1653-1656. Accessed February 22, 2021.
  5. Gee J, Marquez P, Su J, et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. MMWR Morbid Mortal Wkly Rep. ePub: February 19, 2021. Accessed February 22, 2021.
  6. CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:125-129. Accessed February 25, 2021.
Issue
The Journal of Family Practice - 70(2)
Issue
The Journal of Family Practice - 70(2)
Page Number
audio
Page Number
audio
Publications
MDedge Family Medicine
The Journal of Family Practice
Covid ICYMI
Publications
MDedge Family Medicine
The Journal of Family Practice
Covid ICYMI
Topics
COVID-19 Updates
Infectious Diseases
Vaccines
Article Type
Audio
Display Headline
COVID-19 vaccines: New candidates & answers to commonly asked questions
Display Headline
COVID-19 vaccines: New candidates & answers to commonly asked questions
Sections
Practice Alert Podcast
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Mon, 02/22/2021 - 13:45
Un-Gate On Date
Mon, 02/22/2021 - 13:45
Use ProPublica
CFC Schedule Remove Status
Mon, 02/22/2021 - 13:45
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Teaser Media
Doug Campos-Outcalt, MD, MPA
Subscribe to Practice Alert Podcast